Otter Creek Advisors LLC raised its holdings in shares of Avantor, Inc. (NYSE:AVTR - Free Report) by 75.1% during the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 213,098 shares of the company's stock after buying an additional 91,431 shares during the period. Avantor comprises 3.6% of Otter Creek Advisors LLC's investment portfolio, making the stock its 9th largest position. Otter Creek Advisors LLC's holdings in Avantor were worth $5,513,000 as of its most recent SEC filing.
Other institutional investors also recently bought and sold shares of the company. Versant Capital Management Inc increased its position in shares of Avantor by 2,003.6% during the second quarter. Versant Capital Management Inc now owns 1,157 shares of the company's stock worth $25,000 after acquiring an additional 1,102 shares during the last quarter. Blue Trust Inc. increased its holdings in Avantor by 1,830.3% during the 2nd quarter. Blue Trust Inc. now owns 1,467 shares of the company's stock worth $31,000 after purchasing an additional 1,391 shares during the last quarter. UMB Bank n.a. acquired a new position in shares of Avantor in the 3rd quarter valued at approximately $49,000. Nisa Investment Advisors LLC boosted its stake in shares of Avantor by 69.6% during the 3rd quarter. Nisa Investment Advisors LLC now owns 2,035 shares of the company's stock valued at $53,000 after buying an additional 835 shares during the last quarter. Finally, GAMMA Investing LLC grew its position in shares of Avantor by 89.9% during the third quarter. GAMMA Investing LLC now owns 2,715 shares of the company's stock worth $70,000 after buying an additional 1,285 shares in the last quarter. 95.08% of the stock is currently owned by hedge funds and other institutional investors.
Insider Activity
In related news, CAO Steven W. Eck sold 3,525 shares of the business's stock in a transaction that occurred on Thursday, September 5th. The stock was sold at an average price of $25.06, for a total transaction of $88,336.50. Following the sale, the chief accounting officer now owns 29,544 shares of the company's stock, valued at $740,372.64. The trade was a 10.66 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Corporate insiders own 1.50% of the company's stock.
Avantor Stock Performance
AVTR stock traded up $0.46 on Friday, reaching $20.82. The company's stock had a trading volume of 4,344,989 shares, compared to its average volume of 6,488,087. Avantor, Inc. has a 52 week low of $19.59 and a 52 week high of $28.00. The company has a debt-to-equity ratio of 0.84, a current ratio of 1.54 and a quick ratio of 1.06. The company has a market capitalization of $14.17 billion, a P/E ratio of 44.59, a price-to-earnings-growth ratio of 2.39 and a beta of 1.35. The firm has a fifty day moving average of $24.01 and a two-hundred day moving average of $23.89.
Analyst Ratings Changes
Several equities research analysts have recently weighed in on AVTR shares. Stifel Nicolaus boosted their target price on shares of Avantor from $27.00 to $28.00 and gave the stock a "buy" rating in a research report on Monday, July 29th. Royal Bank of Canada reiterated an "outperform" rating and issued a $34.00 target price on shares of Avantor in a research report on Thursday, September 26th. Robert W. Baird dropped their price target on Avantor from $27.00 to $26.00 and set an "outperform" rating on the stock in a research report on Monday, October 28th. UBS Group decreased their price objective on shares of Avantor from $30.00 to $29.00 and set a "buy" rating for the company in a report on Tuesday, October 8th. Finally, Wells Fargo & Company reduced their price target on shares of Avantor from $30.00 to $28.00 and set an "overweight" rating on the stock in a research report on Monday, October 28th. Three research analysts have rated the stock with a hold rating and twelve have assigned a buy rating to the company. According to data from MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and a consensus target price of $27.57.
Check Out Our Latest Report on Avantor
Avantor Company Profile
(
Free Report)
Avantor, Inc engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.
Recommended Stories
Before you consider Avantor, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Avantor wasn't on the list.
While Avantor currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking to avoid the hassle of mudslinging, volatility, and uncertainty? You'd need to be out of the market, which isn’t viable. So where should investors put their money? Find out with this report.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
